Novavax Covid-19 vaccine to be rolled out in Australia from next month
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
By
Markets
Latest in
Markets
Antibacterial resistance needs a global-scale response like Covid-19
On January 19, The Lancet published the paper 'Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis'. This…
By
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
With booster programmes underway across the globe, researchers are exploring which vaccine combinations could be most effective.
By
GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
Restrictive Medicare coverage spells continued uncertainty for Aduhelm
Despite Aduhelm’s first-to-market advantage, months of controversy following the drug’s approval have been a major setback.
By
Endometriosis: how the market has developed and where it needs to be
There is a need for greater endometriosis awareness across the market, with the development of non-invasive diagnosis and more efficient…
By
UK life sciences trade group calls for oral Covid-19 antiviral investment
The UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK…
By